To investigate the developmental, physiological and pathophysiological roles of human cardiac myosin light-chain 1 (LCls), we developed two novel monodonal antibodies (KA1 and KB1) against human cardiac LCls and examined LCls in normal and pathological hearts immunohistochemically. KA1 and KB1 were specific only for atrial LC1 (ALC1) and for both ALCl and ventricular LCl (VLCl), respectively, in human hearts. Among human tissues tested, including skeletal muscle, vascular smooth muscle, and liver, KA1 did not ansreact with proteins in any other tissues than atria, whereas KB1 crossreacted with the slow-type LCl of skeletal muscle. Among adult mammalian hearts of several other species including pig, dog, hamster, and rat, KA1 and KB1 crossreacted only with ALCl and with both ALCl and VLC1,
Introduction
Myosin, a major contractile protein in the thick filament of cardiac muscle, is composed of two heavy chains (HCs) associated with two pairs of light chains (LCs) (1) . HCs are classified into a and fi types, and the expression of these isoforms is regulated by developmental (2, 3) , hormonal (2, 4, 5) , and hemodynamic changes (6-8) in small mammals. HCs largely determine myosin ATPase activities (9) . which are known to correlate with the contractile velocity of the muscle (IO), and therefore it has been recognized that HCs are the most important subunit in the contractile function, and that such a transition of the isoforms has been considered as a qualitative adaptation in the biolqgical composition of myocardial cells for new functional requirements (11). However, only the fi type is detected ' Supported in part by a Grant-inhid for Scientific Research from the Ministry of Education, Science and Culture, Japan. * Correspondence to: Dr. Hirofumi Yasue, Div. of Cardiology, Univ. School of Medicine, 1-1-1 Honjo, Kumamoto City 860, Japan, respectively. ALCl was strongly and uniformly observed in human fetal atria and ventricles and in normal adult human atria, but sporadically in normal adult human ventricles. In the overloaded ventricle (dilated cardiomyopathy), ALCI was highly augmented but not uniform. These results suggest that the fetal VLC1 is immunohistochemically identical to the adult type of A X 1 and that ALCl is expressed homogeneously in human fetal ventricles and sporadically in normal adult ventricles, and is re-expressed heterogene- in human ventricles, regardless of developmental and hemodynamic changes (8, 12) .
On the other hand, LCs are classified into non-phosphorylatable, alkali type (LC1) and phosphorylatable, regulatory type (LC2), and there are at least two isoforms of LC1 and LC2: ALCl and VLC1, and ALCZ and VLC2, respectively (13) . ALCl and ALC2 are the major forms of LCs in atria, and VLCl and VLC2 in ventricles (13). ALCl has been demonstrated in increased amounts in the overloaded human ventricle by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (14) and by two-dimensional gel electrophoresis (15) . ALCl was also found to be abundant in the fetal ventricle, whereas it was demonstrated only slightly in the adult ventricle by two-dimensional gel electrophoresis (16).
The developmental, physiological and pathophysiological roles of the human cardiac LCls have not yet been determined. The availability of monoclonal antibodies (MAb) against human cardiac X I S would greatly facilitate the study of patients with cardiac hypertrophy and/or failure from whom myocardial biopsy specimens can be obtained. In this study, we developed two novel MAb against human cardiac LCk and examined LCls in human fetal hearts and in normal and pathological adult hearts by use of these antibodies (17). FLJJIMCYID, YASUE, NAKAO, YAMAMOTO, HITOSHI, JOUGASAKI, OKUMURA, OGAWA, TAKATSU, MIYAMOTO
Materials and Methods
Autopsy Specimens. Normal adult human hearts (n = 10) were obtained at autopsy from patients who died without cardiovascular diseases, skeletal muscle disease, or liver disease. Heart tissue specimens were obtained from both atria, both ventricles, and the interventricular septum. Iliopsoas muscle, aorta, and liver were also obtained at autopsy. These were regarded as normal adult human tissues. All of the specimens were obtained within 3 hr after death and were immediately frozen in liquid nitrogen and stored at -8O'C until use.
Human Fetal Hearts. Human fetuses (n = 5) between weeks 7-12 of gestation, obtained by legal abortions without vasoconstrictive prostaglandin instillation, were used for the present study. In each case informed consent was obtained from the parents. Heart tissues were carefully removed from the thoracic cavity under a stereomicroscope within 3 hr after abortion. The fetal age was determined on the basis of the crown-rump length and the degree of development of various organs, such as retinal pigmentation and development of extremities. The time from the initiation of abortion to the collection of samples was within 3 hr.
Biopsy Specimens. Endomyocardial biopsy was performed at the time of cardiac catheterization for patients with dilated cardiomyopathy (DCM; n = 10, nine men and one woman, ages ranging from 32-71 years, mean age of 55 years). Biopsy specimens were obtained percutaneously by the brachial artery approach with a bioptome (Machida; Osaka, Japan). Three to four specimens were obtained from the posterior wall of the left ventricle. During the procedures no complication occurred in any patient. The clinical diagnosis of DCM was based on history, physical examination, chest X-ray, electrocardiogram, echocardiogram, pathological findings, cardiac catheterization, and angiocardiography, including left ventriculography and coronary arteriography. This study was in agreement with the guidelines of the ethical committee of our institution. Written informed consent was obtained from each patient.
Experimental Animals. Adult pig hearts (n = 5) were obtained from a local slaughterhouse. Adult hearts of mongrel dogs (n = 5). golden hamsters (n = 5). and Wistar rats (n = >) were obtained under anesthesia by ether inhalation. Tissue specimens were obtained from both atria and both ventricles. Tissue specimens were immediately frozen in liquid nitrogen and stored at -8O'C until use.
Preparation of Monoclonal Antibodies. Whole cardiac myosin was prepared by the dilution method (18) from human atrial myocardium obtained at autopsy. Myosin was further purified on a DEAE-cellulose (DE-52) (Whatman BioSystems; Clifton, NJ) column by a linear gradient (0-0.4 M KCl), (Wako Pure Chemical Industries; Osaka, Japan). Myosin light chains were extracted and separated from the purified myosin by the method of Perrie and Perry (19) . Myosin light chains prepared were subjected to SDS-PAGE in 18% acrylamide gel by the method of Laemmli (20) . The protein band of ALCl was cut from the gel and ALCl was electrophoretically extracted from the gel. VLCl was purified by the same method, using human ventricular myocardium obtained at autopsy.
Hybridomas producing anti-myosin antibodies were obtained by fusion of myeloma cells (P3 x &Ag8,6>3) with isolated spleen cells of Balblc (female, 6-week) mice immunized with purified ALCl(0.2 ml of 0.5 mglml purified ALCl solution administered SC at 1-&week intervals). Hybridomas were cultured by the method described previously (21). Hybridoma supernatants were screened by immunoblotting with the purified myosin. The cells that produced monoclonal antibodies were cloned twice by limiting dilution. Two kinds of monoclonal antibodies (MAb) were obtained (KA1 and KB1).
Immunoblotting. Tissue specimens were coarsely minced and homogenized in a %-buffered isotonic solution containing 10 mM %-HC1, pH 7.5 (Kishida Chemical; Osaka, Japan, and Nacalai Tesque; Kyoto, Japan), 250 mM sucrose (Kanto Chemical; Tokyo, Japan), 1 mM EDTA (Dojindo Laboratories; Kumamoto, Japan), and 1 mM phenylmethylsulfonyl fluoride (Sigma; St Louis, MO) with an Ultra Turrax (setting max. speed for 30 sec x 2) (IKA-WERK, UK) at 4°C. Proteins of the crude homogenate ( 5 pg) were separated by SDS-PAGE in 18% acrylamide gel and electrophoretically transferred to a filter membrane (GVHP0010) (Millipore; Yonezawa, Japan) with Trans Blot (BioRad Laboratories; Richmond, CA) at 80 V for 5 hr by the method of Towbin et al. (22) . After the transfer, membranes were incubated with 2.5 % bovine serum albumin (BSA; Sigma) in Tris-buffered saline containing 100 mM Tris-HC1, pH 7.5, and 150 mM NaCl (Wako) at room temperature for 1 hr to block nonspecific binding sites, and were then incubated with KA1(1:50,000 dilution) or KB1(1:2O,OOO dilution) at room temperature for 1 hr. The immunoreactivity was detected by the avidin-biotin-peroxidase complex method (Vectastain ABC kit; Vector Laboratories, Burlingame, CA) with 3,3'-diaminobenzidine tetrahydrochloride (DAB; Sigma) as a chromogen. For other membranes, protein was stained with Amido Black (Merck; Darmstadt. Germany).
Immunohistochemistry. Peroxidase (POD) (Boehringer; Mannheim, Germany )-conjugated KAl-F(abY [KAl-F(ab)'-POD] and POD-conjugated KB1-IgG (KB1-IgG-POD) with the maleimide method were prepared as described by Ishikawa et al. (23) . Briefly, KAI and KBl were purified from ascites fluid by affinity chromatography on a column ofprotein A-Sepharose 4LCB (Pharmacia LKB Biotechnology AB; Uppsala, Sweden). Purified KA1 was digested to KAl-F(ab)' with pepsin (Boehringer), which was reduced to KAl-F(ab). The resulting KAl-F(ab) was conjugated with POD by the maleimide method (KAl-F(ab'tPOD]. Purified KB1 was reduced and conjugated with POD (KB1-IgG-POD). The direct immunoperoxidase method was used with KAl-F(abtP0D and KBI-IgG-POD for the immunohistochemical staining.
All tissue specimens were immediately fixed with the Zamboni fixative (24) at 4°C for 6 hr, and the samples were washed with phosphate-buffered saline (PBS; 50 mM sodium phosphate, pH 7.4, and 150 mM NaCI) containing lo%, 15%. and 20% sucrose at 4°C overnight for each step. After rinsing in PBS containing 20% sucrose and 10% glycerol (Wako) at 4'C for 1 hr, they were embedded in cm3 compound (Tissue-Tek) (Miles; Elkhart, IN), quickly frozen in dry ice-acetone (Wako), and stored at -8O'C. Frozen tissue specimens were cut with a cryostat (Bright Instrument; Cam-' bridgeshire, UK) into 8-pm thick sections and mounted on poly-L-lysine (Sigma)-coated slides. To block endogenous peroxidase activity, the sections were immersed in 0.5% periodate solution for 10 min and washed three times with PBS. After washing well with PBS, the sections were incubated with PBS containing non-immune mouse serum (MO dilution) and 0.5% BSA at room temperature for 1 hr to block nonspecific binding sites. Furthermore, the sections were incubated with KAl-F(ab)-POD ( 5 pglml) or KB1-IgG-POD (10 pglml) in a covered chamber at 4'C overnight and washed three times with PBS. The final reaction was achieved by incubating the sections with freshly prepared reagent containing 40 mg DAB in 100 ml of 0.05 M Tris-HC1 buffer, pH 7.6, with 0.01% hydrogen peroxide (Mitsubishi Gas Chemical; Tokyo, Japan). The nuclei were counterstained with hematoxylin (Merck). To test the specificity of the antibodies used, each MAb pre-absorbed with purified ALCl or purified VLCl was applied to the samples at different concentrations instead of the untreated antibody. The presence or absence of immunoreactive products for KA1 or KB1 was judged by three independent observers.
The monoclonal antibodies used were equally reactive with both fixed and unfixed tissues. In the present study, the tissues were fived with the Zamboni fixative, as described above.
To evaluate the relative amount of expression of ALCl in the human ventricle, we calculated the proportion of ALC1-positive myocardial cells (%. number of positive myocardial cells of 300 myocardial cellsl300 in autopsy samples and the number of positive myocardial cells of total number of myocardial cellsltotal number of myocardial cells in biopsy samples).
Statistical Analysis. Data were expressed as mean t standard error (SE). To evaluate the statistical significance among the various groups, one-way analysis of variance (ANOVA) was performed and, when necessary. Schdfc's Ftest. p<O 
Results

Classification of the Monoclonal Antibodies
The subtypes of the monoclonal antibodies prepared were classified by a mouse monoclonal antibody isotype kit. Both KA1 and KBI were found to be IgGl, K class among IgA, IgM, IgG1, IgG2a, Ig&, and IgG3, and K and X.
Specz3city of the Monoclonal Antibodies
Two kinds of MAb were obtained (Figure 1) . One was specific for ALCl (KA1) and the other for both ALCl and VLCl (KB1). KA1 recognized the purified ALCl and the protein of the equivalent migration as ALCl in the homogenate of normal adult human atrium ( Figures 1A and 1B) . On the other hand, KBI recognized both ALCl and VLC1, which were purified and existed in the homogenate of normal adult human atrium or ventricle ( Figures 1A  and IC ). There were no differences in reactivity with KAI and KBI between the right and left atrium, and among the right ventricle, the left ventricle, and the interventricular septum. Protein staining (Amido Black) and immunostaining (KB1) of standard amounts of VLCl and ALCl were determined by the densitometric analysis. The ratio of the crossreactivity between VLCl and ALCl was found to be 90.7%, indicating that ALCl showed slightly higher im- A munoreactivity. No other protein in the homogenate crossreacted with, the antibodies. Both ALCl and VLCl were not immunoreactive with IgG from non-immune serum.
Crossreactivities of the antibodies with the various adult human tissues were examined. Among the human tissues examined, KA1 recognized only ALCl (Figures 2A and 2B ), whereas KB1 crossreacted with the slow-type LC1 of skeletal muscle (iliopsoas muscle) in addition to ALCl and VLCl (Figures 2A and 2C) . Any protein in the homogenate of the smooth muscle (aorta) and the non-muscle tissue (liver) did not crossreact with KAl and KB1 (Figure 2) .
Crossreactivities of the antibodies with the atrium and ventricle of the normal adult pig, dog, hamster, and rat were also examined. KAI recognized only ALCl in the homogenate of the tissues ( Figure 3A) , whereas KB1 crossreacted with both ALCl and VLCl in these species ( Figure 3B) . No differences were observed between the right and left atria and ventricles. Molecular masses of ALCl and VLC1 and their relative mobilities by SDS-PAGE slightly differed in each species. In human and pig hearts, VLCl migrated faster than ALCl by SDS-PAGE, whereas the hearts of other species tested showed reversed positions of the LCls. Interestingly, KA1 did not crossreact with chicken cardiac LCls of the atrium and ventricle, whereas KB1 crossreacted with the chicken cardiac LCls (data not shown).
Immunohistochemical Localization of LCls in Human Heart
Immunohistochemical localization of LCls in the human fetal heart and in normal and pathological adult hearts (DCM) were examined with KA1 and KBI (Figures 4 and 5) . In the normal adult heart, the immunoreactivity of ALCl was strongly and uniformly recognized in the atrium ( Figure 4A ) but was only sporadically ob- served in the ventricle ( Figure 4C ). Furthermore. the immunoreactivity of ALCl was clearly recognized in some myocardial cells of the ventricle. and the striated bands were clearly detected on the magnified view (Figure 4E) . All myocardial cells of the atrium (Fig  w e 4B) and ventricle (Figure 4D) were strongly and uniformly immunostained with KB1. which recognizes both ALCl and VLCI. There were no differences in the reactivity with KAI and KB1 between the right and left atria, or among the right ventricle. the left ventricle, and the interventricular septum, and between endocardial and epicardial regions. Endocardium. epicardium, and other connective tissues were not immunostained with KAl and KB1 ( Figures 4A-4E) .
A
The immunoreactivity of ALCl was strong and uniform in all portions of the atria and ventricles of fetal heart ( Figure SA) . Vascular smooth muscle and other connective tissues were not immunestained ( Figure SA) . It is interesting to note that the immunoreactivity of ALCl was highly augmented in the overloaded ventricle of the patients with DCM. whereas it was only sporadically observed in the normal adult ventricle (Figures 5B and 4C) . Myocardial cells were hypertrophic and had enlarged and bizarre-shaped nuclei. Some myocardial cells showed vacuolar changes. The immunoreactivity of ALCl was not uniform, and various staining lcvels of myocardial cells were seen in the ventricle of the patients with DCM. The stronger immunoreactivity of ALCl tended to be in the larger cells. Figure 5B shows an example of the specimen from the ventricle of a patient with DCM stained with KA1.
To evaluate the relative amount of expression of ALCl in the human ventricle, we calculated the proportion of ALC1-positive myocardial cells (Table 1) . ALCl was expressed in only 22.60 * 1.58% of myocardial cells in the normal adult ventricle, whereas it was expressed in 100% in the fetal ventricle and 64.57 * 2.42% in the ventricle of patients of DCM. The difference was highly significant ( p < 0.001). There were some variations of staining among samples in the ventricles of patients with ).
Discussion
In the present study we developed two kinds of monoclonal antibodies: KA1, which was specific for only ALC1, and KBI, which was specific for both ALCl and VLCl of the human heart and which crossreacted with the slow-type LC1 of human skeletal muscle. These antibodies also crossreacted with ALCl (KA1) and both ALCl and VLCl (KB1) of several other mammals. By use of these MAb, we could demonstrate immunohistochemically that ALCl appears The heterogeneity of ventricular myocardial cells with respect to ALCl expression may be related to the polymorphism of the myosin molecule. The present study suggests that cell types with different contractile properties coexist in the ventricle of the human heart.
A recent study of human genes revealed that the amino acid sequences of ALCl and VLCl are homologous by 79.4% (26). Fortunately, KA1 recognized the specific epitope of ALCl but not the common epitopes of ALCl and VLC1, so KA1 was specific for ALC1. Moreover, KA1 and KB1 crossreacted with ALCl and both ALCl and VLCl of several other mammals, respectively. These results indicate that both ALCl and VLCl in several mammals are homologous. Barton et al. (27) reported that VLCl and slow-type LC1 of the skeletal muscle are encoded by the same gene in the mouse. The present data in the human were consistent with theirs, because KB1 recognized both VLCl and slow-type LC1 and the migration by SDS-PAGE was identical between the two LCls.
ALCl was not well detected in the normal adult ventricle by two-dimensional polyacrylamide gel electrophoresis (15J6). In some cases we did not recognize ALCl in the normal adult ventricles by immunoblotting, but we always detected ALCl in the normal adult ventricle. This demonstrates that the immunohistochemical study is not quantitative but rather is qualitative. The immunostaining of the tissues depends on the distribution andlor density of antigens in the cells and the tissues. The immunohistochemistry and immunoblotting have the respective properties, even though the same substance is detected.
The direct method used for the immunohistochemistry was more sensitive and presented clearer pictures than the indirect method (28). By the indirect method, we could not clearly observe that ALCl was expressed in some myocardial cells of the normal adult human ventricle. However, the striated bands were clearly observed in all samples by the direct method. Price et al. (16) reported that the fetal VLCl (FLCl), which is the major component of LC1 in the ventricle throughout the latter half of gestation and which disappears during the postnatal period, is indistinguishable from adult ALCl by isoelectric focusing and subsequent two-dimensional polyacrylamide gel electrophoresis.
We previously reported that FLCl and ALCl are probably identical (14). In the present study, we showed that the human fetal ventricle was strongly and uniformly immunostained with KA1, which is specific for ALC1.
ALCl has been shown to be re-expressed in the overloaded ventricle of the heart by two-dimensional gel electrophoresis (15). We reported that LC1 newly expressed in the overloaded ventricle was indistinguishable from ALCl and FLCl with respect to the migration by SDS-PAGE, peptide mapping, and immunoreactivities (14) . The present study further shows that ALCl is strongly expressed in the overloaded ventricle of patients with DCM. The heterogeneity of ventricular myocardial cells with respect to ALCl expression may be related to the heterogeneous distribution of pathological cells and their degree of hypertrophy and/or degeneration, resulting in polymorphism of the myosin molecule.
We previously reported that atrial natriuretic polypeptide (ANP), which is synthesized and secreted mainly from the atrium in adult mammals (29), is immunohistochemically strongly demonstrated in the human fetal ventricle, in the adult human ventricle with DCM (28) and with myocardial infarction (30), but not in the normal adult ventricle, and that ANP is released in increased amounts from the left ventricle of the patients with DCM (31). Furthermore, the expression of ANP gene in the ventricle of human failing heart was augmented (32). These results suggest that the substances expressed during the fetal period are re-expressed in the overloaded ventricle. This speculation is supported by the findings that several substances such as P-type HC protein (33) and messenger RNA (33,34) , a-skeletal actin messenger RNA (34), and MB type creatine kinase isozyme (35) are also expressed in the fetal ventricle and re-expressed in the overloaded ventricle, although they are rarely detected in the normal adult ventricle.
In conclusion, we developed two types of monoclonal antibody against human cardiac myosin light-chain 1, i.e., KA1 and KB1, and have demonstrated that ALCl is expressed strongly in the overloaded ventricle as well as in the fetal ventricle in human by immunohistochemistry. KA1 and KB1 are therefore useful tools for analysis of LCls in normal and pathological hearts, and by using these tools we may be able to elucidate the developmental, physiological, and pathophysiological roles of LCls.
